findmyKOL

Edith Perez, MD

Enriched profile

Chief Medical Officer, Cornerstone Specialty Network · Mayo Clinic

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Jacksonville, FL · Southeast · United StatesSpecialtyHematology / OncologyFocusBreast Cancer Treatment Studies+4
Active KOLfindmyKOL type: NationalLatest publication2025Online presenceNone verifiedPayments2021–2025NIH funding2008–2015

Edith Perez is Chief Medical Officer, Cornerstone Specialty Network at Mayo Clinic. OpenAlex indexes 670 publications with 60,050 citations (h-index 96); ClinicalTrials.gov lists 26 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Hematology / Oncology profiles in the findmyKOL directory.

Data verified 12 Oct 2026

Overview

Updated 14 Oct 2026

Edith Perez, MD, is Chief Medical Officer, Cornerstone Specialty Network at Mayo Clinic. The public record shows 670 publications with 60,050 citations (h-index 96), centered on Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology. It also documents an investigator role on 26 registered clinical trials, industry payments reported by 8 companies, 2 NIH-funded awards (2008–2015).

  • Most recent indexed publication: 2025 · Breast cancer research and treatment
  • Top research focus: Breast Cancer Treatment Studies
  • 26 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 8 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Breast Cancer24 trialsLung Cancer (NSCLC/SCLC)2 trialsSmall Cell Lung Carcinoma1 trialBreast Neoplasms, Male1 trialCardiotoxicity1 trialNeoplasms, Hormone-Dependent1 trialGastroesophageal Cancer

Research focus

OpenAlex concept fingerprint
Breast Cancer Treatment StudiesHER2/EGFR in Cancer ResearchCancer Treatment and PharmacologyGastric Cancer Management and OutcomesBreast Lesions and Carcinomas

Drugs & molecules

across trials, industry payments and publications
Enhertugeneric · TrastuzumabClinical trials—Industry payments2Publications5PaclitaxelClinical trials1Industry payments—Publications6CyclophosphamideClinical trials1Industry payments—Publications1DoxorubicinClinical trials1Industry payments—Publications1EpirubicinClinical trials1Industry payments—Publications—Epoetin alfaClinical trials1Industry payments—Publications—FilgrastimClinical trials1Industry payments—Publications—FluorouracilClinical trials1Industry payments—Publications—Nerlynxgeneric · NeratinibClinical trials—Industry payments1Publications—Udenycageneric · PegfilgrastimClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Cornerstone Specialty Network LLCClinical trials—Industry payments56Genentech, Inc.Clinical trials—Industry payments34Alliance for Clinical Trials in OncologyClinical trials11Industry payments—National Cancer Institute (NCI)Clinical trials4Industry payments—Daiichi Sankyo Inc.Clinical trials—Industry payments3Eastern Cooperative Oncology GroupClinical trials3Industry payments—Mayo ClinicClinical trials3Industry payments—Caris MPI, Inc.Clinical trials—Industry payments1Coherus Biosciences Inc.Clinical trials—Industry payments1ETOP IBCSG Partners FoundationClinical trials1Industry payments—Eventus Diagnostics LtdClinical trials1Industry payments—Genentech USA, Inc.Clinical trials—Industry payments1Gilead Sciences, Inc.Clinical trials—Industry payments1Intarcia TherapeuticsClinical trials1Industry payments—NCIC Clinical Trials GroupClinical trials1Industry payments—Puma Biotechnology, Inc.Clinical trials—Industry payments1TheradexClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
670publications

Distinct works indexed by OpenAlex, matched via ORCID; 8 in PubMed.

60,050citations

Total citations across indexed works.

96h-index

Hirsch index (OpenAlex). i10-index 340.

Clinical & industry

trials, payments and federal funding
26clinical trials

Investigator role on registered studies.

View trials ↓
8companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
2NIH grants · 2008–2015

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 26 registered studies on ClinicalTrials.gov. The most recent:

All 26 trial records: search, sort and filter.Explore →

Industry payments

Updated 14 Oct 2026

8 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

All 15 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

NIH funding

Updated 14 Oct 2026

2 NIH research awards on record, funded 2008–2015 per NIH RePORTER. The latest:

All 20 award records: search, sort and filter.Explore →

Congress activity

Updated 14 Oct 2026

161 congress contributions (1992–2025) across AACR, ASCO, ASTRO, ESMO, SABCS per OpenAlex. The most recent:

All 161 congress records: search, sort and filter.Explore →

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 8 publications: search, sort and filter.Explore →

Most-cited works

by citation count (OpenAlex)
  1. 01
    Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
    Article5,356 citations2005
    doi.org ↗
  2. 02
    Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
    Article4,028 citations2013
    doi.org ↗
  3. 03
    The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
    Article3,111 citations2014
    doi.org ↗
  4. 04
    Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
    Article3,081 citations2007
    doi.org ↗
  5. 05
    A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer
    Article1,800 citations2003
    doi.org ↗
All 670 cited works: search, sort and filter.Explore →

Network

Updated 14 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Nancy E. Davidson86Silvana Martino74James N. Ingle73George W. Sledge71Joseph A. Sparano56Alvaro Moreno‐Aspitia55E. Aubrey Thompson54Amylou Constance Dueck50Julie R. Gralow49Gerardo Colón‐Otero45Sunil Badve41Karla V. Ballman39Brian M. Necela36Kathleen Tenner36Saranya Chumsri34Lori J. Goldstein33Frederick L. Baehner33Krishna R. Kalari33Wilma L. Lingle31Keith L. Knutson31Donald W. Northfelt31Monica Madden Reinholz31Yan W. Asmann30Xochiquetzal J. Geiger30Hope S. Rugo30Lawrence N. Shulman29Steven Shak29Eric P. Winer29E. Aubrey Thompson29Martine J Piccart29David W. Hillman29Nadine Norton28Antonio C. Wolff28Kathleen I. Pritchard28Vera Jean Suman28Matthew Philip Goetz27Peter Andrew Kaufman27Daniel Serie26Ahmad Hussein Awada25Javier Cortés25

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Vice Chairperson

    Scientific Advisory Committee, American Association for Cancer Research

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aacr.org ↗
  • Group Vice Chair

    Alliance for Clinical Trials in Oncology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancerletter.com ↗
  • Chair

    Breast Cancer Committee, North Central Cancer Treatment Group

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lbbc.org ↗
  • Editorial Board Member

    Multiple Academic Journals

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
  • Speaker and Reviewer

    Living Beyond Breast Cancer

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lbbc.org ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Chief Medical Officer

    Bolt Biotherapeutics

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aacr.org ↗
  • Board Member

    Food Allergy Research Foundation

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
  • Board Member

    Puerto Rico Science, Technology & Research Trust

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
  • Member of National Cancer Institute committees
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.